Virginia lawmakers introduced a bill to reduce the penalty for possessing peyote, ibogaine, psilocybin, or psilocin from a Class 5 felony to a $100 fine.
A separate bill has been filed that’s nearly identical, except it focuses on psilocybin and psilocin only.
Architect David Benjamin wants to make the construction industry more sustainable using (you guessed it) mushrooms!
He constructed a 40-foot-tall structure using bricks grown from mushroom mycelium.
The bricks are lightweight yet durable and can be grown in five days without emitting carbon or producing waste.
Ketamine One (MEDI) began trading on the OTCQB marketplace under the symbol ‘KONEF’.
We’re collaborating with experts at Entheon Biomedical (ENBI) to bring you a special virtual event on February 3rd.
Here’s what you can expect to learn:
You’ll hear insights and stories from:
Now is your chance to get your questions answered by industry experts and connect with fellow members of the Daily Mushroom Community. We can’t wait to see you there. Register for free here.
A Missouri Rep. filed a bill to expand the state’s right-to-try law to include psilocybin, MDMA, DMT, ibogaine, LSD, mescaline, and peyote. This would grant patients with terminal or debilitating illnesses legal access to the substances.
Delic Holdings Corp. (DELC) announced that it plans to more than double its footprint in the next 18 months by opening 15 new ketamine clinics, which will be strategically located in secondary cities to improve patient accessibility.
Novamind (NM) is hosting a first-of-its-kind study to find out.
The trial will see if ketamine-assisted therapy can enhance the effectiveness of buprenorphine, a first-line addiction medication, in treating opioid use disorder.
Will the two drugs finally be able to conquer this treatment-resistant condition?
Senator Scott Wiener announced that he is once again pushing for a psychedelic decriminalization bill in California after halting it last year, and believes it has a 50/50 chance of being passed.
To generate support, veterans are meeting with Assembly members and changes may be made to possession limits and types of psychedelics included. Read more…
Italian officials verified 630,000 signatures collected in support of a measure to decriminalize cultivation of marijuana and psilocybin mushrooms.
If the measure is approved by the Constitutional Court, which will be announced on February 15, it will appear on a ballot this spring.
“Given today’s scientific understanding of psilocybin’s high potential therapeutic value and low risk of dependence, a change of its status as a Schedule I drug is long overdue,” according to Christopher Koddermann.
That’s why he co-founded The International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) – an initiative that’s pushing for psilocybin to be rescheduled on a global scale.
ITPRI aims to reschedule psilocybin through the United Nations’ Convention on Psychotropic Substances, which was enacted over 50 years ago 😮 This would significantly reduce the regulatory barriers that impede psilocybin research and access to treatment.
So yes, rescheduling is long overdue, but better late than never!
